Ethoxycarbonyl Group

Ethoxycarbonyl Group

SCHEMBL374751

CCOC=O.Cl

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Ethoxycarbonyl Group. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 725 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-211274701-U Heating and cooling device for preparing ethyl formate hydrochloride 四川同晟氨基酸有限公司 2020-08-18 CN claimed
CN-107202777-B A kind of small molecule chip, its construction method, its application and its detection method 广州高通生物技术有限公司 2019-11-26 CN claimed
CN-110226469-A A kind of implantation methods of edible rear low photosensitivity allergic reaction three-coloured amaranth 霍山县安绿园农业发展有限公司 2019-09-13 CN claimed
CN-109678811-A A kind of asymmetric preparation method of florfenicol intermediate cyclic product 湖北中牧安达药业有限公司 2019-04-26 CN claimed
CN-109512742-A A kind of man's essential oil shower condensation and preparation method thereof 株洲千金药业股份有限公司 2019-03-26 CN claimed
CN-109468061-A Recycle-water reservoir walls method for preparing antibiotic coating 佛山市南海区里水镇经济促进局 2019-03-15 CN claimed
CN-109414655-A Coated porous polymer membranes 恩特格里斯公司 2019-03-01 CN claimed
CN-108794474-A Rutaecarpin derivative and its preparation method and application with multiple target point antitumor activity 中国人民解放军第二军医大学 2018-11-13 CN claimed
CN-108794413-A A kind of synthetic method of 1,2,4- triazoles -3- formamides 青岛科技大学 2018-11-13 CN claimed
CN-108740356-A Purposes of the lauroyl arginine ethyl ester derivative as feed addictive 华东师范大学 2018-11-06 CN claimed
CN-101318907-A Method for preparing benzoic-2-[[1-methyl-2-[3-(trifluoromethyl)-phenyl] ethyl] amido] ethyl ester hydrochlorate SHANDONG XINHUA PHARMACEUTICAL (CN) 2008-12-10 CN claimed
CN-101215247-A Method for synthesizing pyrethroid hapten compounds UNIV ZHEJIANG (CN) 2008-07-09 CN claimed
CN-101023056-A Levodopa prodrugs, and compositions and uses thereof XENOPORT INC (US) 2007-08-22 CN claimed
CN-1986919-A Process of producing polyacrylic fiber dyeable with both cationic dye and acid dye SHANGHAI PETROCHEMICAL CO LTD (CN) 2007-06-27 CN claimed
CN-1986918-A Process of producing polyacrylic fiber dyeable with both cationic dye and acid dye SHANGHAI PETROCHEMICAL CO LTD (CN) 2007-06-27 CN claimed
CN-1629146-A Process for synthesis of chiral 2-substituted piperazine and its derivatives SHANGHAI INST MATERIA MEDICA (CN) 2005-06-22 CN claimed
CN-1126732-C Process for preparing benzoxy -2-[[1-methyl-2-[3-(trifluoromethyl)-phenyl]ethyl]amino] carbethoxy hydrochloride XINHUA PHARMACEUTICAL CO LTD S (CN) 2003-11-05 CN claimed
CN-1377876-A Process for preparing benzoxy -2-[[1-methyl-2-[3-(trifluoromethyl)-phenyl]ethyl]amino] carbethoxy hydrochloride XINHUA PHARMACEUTICAL CO LTD S (CN) 2002-11-06 CN claimed
EP-0640628-A2 Crosslinked polyacrylic acids having low solvent residue, a process for the preparation therof and the use thereof as thickening agents 3V SIGMA S.p.A (IT) 1995-03-01 EP claimed
US-5342911-A Solvent mixture containing methylene chloride and an ester 3V INC. (US) 1994-08-30 US claimed